Differential Cardiometabolic Outcomes of Leuprolide Versus Spironolactone in Women With Polycystic Ovary Syndrome

    Myles Goliger, Michael Kozlov, Esther Auerbach … Jason Lazar
    Studysummary Leuprolide may better manage cholesterol and blood pressure in PCOS than spironolactone.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on tandfonline.com →
    Discuss this study in the Community →

    Research cited in this study 9

    1. Causal Relationship Between Inflammatory Cytokines and Polycystic Ovary Syndrome: A Bidirectional Mendelian Randomization Study Journal of Ovarian Research · 2024
    2. Beyond Hormones: A Systematic Review of the Risk of Cardiovascular Diseases in Polycystic Ovary Syndrome Cureus · 2024
    3. Polycystic Ovarian Syndrome: Exploring Hypertension and Cardiometabolic Implications Cureus · 2024
    4. The Efficacy and Safety of Oral and Topical Spironolactone in Androgenetic Alopecia Treatment: A Systematic Review Clinical, Cosmetic and Investigational Dermatology · 2023
    5. Effects of Low-Dose Spironolactone Combined with Metformin or Either Drug Alone on Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Pilot Study International Journal of Endocrinology · 2022
    6. Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth International journal of reproductive medicine · 2014
    7. The Metabolic Effects of Drugs Used for the Treatment of Polycystic Ovary Syndrome Journal of the Turkish-German Gynecological Association · 2013
    8. Relationship Between Androgen Levels and Blood Pressure in Young Women With Polycystic Ovary Syndrome Hypertension · 2007
    9. Comparison of Spironolactone, Flutamide, and Finasteride Efficacy in the Treatment of Hirsutism: A Randomized, Double-Blind, Placebo-Controlled Trial The Journal of Clinical Endocrinology and Metabolism · 2000